A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma (clinicaltrials.gov) - Sep 30, 2026 - P2 | N=15 | Terminated | Sponsor: Alaunos Therapeutics | Unknown status ➔ Terminated; Study closed after Stage 1 (15 of 40 planned patients treated) due to lack of treatment response; criteria to proceed to Stage 2 were not met.
Trial termination • Hepatocellular Cancer • Oncology • Solid Tumor
|